Oniria Therapeutics logo

Oniria Therapeutics jobs and careers

Spain

About Oniria Therapeutics

A shift in cancer treatment methodology makes a world of difference. Oniria Therapeutics is a spin-off from Vall d'Hebron Institute of Oncology (VHIO), the University of Barcelona (UB) and the Catalan Institution for Research and Advanced Studies (ICREA). Oniria Therapeutics is a biotech company focused on the development of first-in-class drugs in the field of precision oncology. It develops therapies to modulate and eliminate dormant tumor cells as a novel targeted strategy to overcome their persistence. Our flagship product allosterically activates TET2, a master epigenetic enzyme.

Founded
2021
Employees
11 to 50
Total funding
$1.3M
Headquarters
Spain

Leadership

The top of Oniria Therapeutics's org chart, with how many people report into each leader.

HPPhoto of Hector G Palmer

Hector G Palmer

Chief Scientific Officer

Jobs at Oniria Therapeutics

No open positions right now. Explore more companies on TheJobsMap.